The Mechanism of the Yigutang-Mediated P13K/AKT/GSK-3<i>β</i> Signal Pathway to Regulate Osteogenic Differentiation of Bone Marrow Stromal Stem Cells to Treat Osteoporosis

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Group</td><td class="align_center">Number</td><td class="align_center">Number of osteoblasts</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Normal</td><td class="align_center">15</td><td class="align_center">26.86 ± 10.2</td></tr><tr><td class="align_left">Model</td><td class="align_center">15</td><td class="align_center">12.45 ± 7.9</td></tr><tr><td class="align_left">Yigutang</td><td class="align_center">15</td><td class="align_center">21.79 ± 9.8</td></tr><tr><td class="align_left">Estrogen</td><td class="align_center">15</td><td class="align_center">20.91 ± 10.3</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of the number of osteoblasts in rats (<i>x</i> ± <i>s</i>).</div>

Evidence-Based Complementary and Alternative Medicine

tab3

Table 3

Table 3: The Mechanism of the Yigutang-Mediated P13K/AKT/GSK-3<i>β</i> Signal Pathway to Regulate Osteogenic Differentiation of Bone Marrow Stromal Stem Cells to Treat Osteoporosis 

Table 3 | The Mechanism of the Yigutang-Mediated P13K/AKT/GSK-3β Signal Pathway to Regulate Osteogenic Differentiation of Bone Marrow Stromal Stem Cells to Treat Osteoporosis 